August 17, 2017 5:58 AM ET

Life Sciences Tools and Services

Company Overview of Icagen, Inc.

Company Overview

Icagen, Inc., a partner research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies. The company provides integrated drug discovery services in the fields of ion channel, transporter, neuroscience, muscle biology, and rare disease targets, as well as various classes of drug discovery targets and therapeutic areas. Its pre-clinical drug discovery services comprise assay development technologies, cell line generation, high-throughput and ultra-high-throughput screening, medicinal chemistry, computational chemistry, and custom assay services. The company was formerly known as XRpro Sciences, Inc. and changed its name to Icagen, Inc. in A...

Research Triangle Park

Suite 350

4222 Emperor Boulevard

Durham, NC 27703

United States

Founded in 2003

74 Employees

Phone:

919-433-3205

Key Executives for Icagen, Inc.

Chief Executive Officer & President
Age: 46
Chief Financial Officer
Age: 49
Chief Commercial Officer
Senior Vice President
Vice President of Research
Compensation as of Fiscal Year 2017.

Icagen, Inc. Key Developments

Icagen, Inc. announced delayed 10-Q filing

On 08/14/2017, Icagen, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Icagen, Inc. Announces Resignation of Benjamin Warner from the Board of Directors and from All Other Positions

Icagen, Inc. announced resignation of Dr. Benjamin Warner from the board of directors of the company and from all other positions . Dr. Warner intends to return his focus to other projects on a full-time basis.

Icagen, Inc. and Omdana Therapeutics, Inc. Announce Collaboration to Pursue Therapies for Patients with Pulmonary Hypertension

Icagen, Inc. and Omdana Therapeutics, Inc. announced a collaboration to help advance the discovery of novel medicines for disorders related to tissue homeostasis and vascular remodeling such as pulmonary hypertension. Omdana will partner with Icagen as an integrated drug discovery team with the goal of developing high-quality, advanced leads ready for clinical trials.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 15, 2017
--
Private Placement
April 12, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Icagen, Inc., please visit www.icagen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.